Giatromanolaki A - Search Results

1

New insights into the normal menstrual cycle-regulatory molecules.

Sivridis E, Giatromanolaki A. Sivridis E, et al. Among authors: giatromanolaki a. Histol Histopathol. 2004 Apr;19(2):511-6. doi: 10.14670/HH-19.511. Histol Histopathol. 2004. PMID: 15024712 Review.

2

Bcl-2 and p53 expression in stage I endometrial carcinoma.

Giatromanolaki A, Sivridis E, Koukourakis MI, Harris AL, Gatter KC. Giatromanolaki A, et al. Anticancer Res. 1998 Sep-Oct;18(5B):3689-93. Anticancer Res. 1998. PMID: 9854478

3

Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.

Kakolyris S, Giatromanolaki A, Koukourakis M, Leigh IM, Georgoulias V, Kanavaros P, Sivridis E, Gatter KC, Harris AL. Kakolyris S, et al. Among authors: giatromanolaki a. Cancer Res. 1999 Nov 1;59(21):5602-7. Cancer Res. 1999. PMID: 10554041

4

Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?

Giatromanolaki A, Sivridis E, Koukourakis MI, Georgoulias V, Gatter KC, Harris AL. Giatromanolaki A, et al. Oncol Res. 1999;11(4):205-12. Oncol Res. 1999. PMID: 10566619

5

Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis.

Koukourakis MI, Flordellis CS, Giatromanolaki A, Koukouraki S, Kapsoritakis A, Potamianos S, Retalis G, Sivridis E, Salsaa B, Harris AL, Maragoudakis MI. Koukourakis MI, et al. Among authors: giatromanolaki a. Clin Cancer Res. 1999 Dec;5(12):3970-6. Clin Cancer Res. 1999. PMID: 10632327 Clinical Trial.

6

Thymidine phosphorylase expression in endometrial carcinomas.

Sivridis E, Giatromanolaki A, Koukourakis MI, Bicknell R, Harris AL, Gatter KC. Sivridis E, et al. Among authors: giatromanolaki a. Clin Exp Metastasis. 1999 Jul;17(5):445-50. doi: 10.1023/a:1006603709248. Clin Exp Metastasis. 1999. PMID: 10651312

7

Lectin-binding patterns in normal, hyperplastic and neoplastic endometrium: the prognostic value of concanavalin A.

Sivridis E, Giatromanolaki A, Koukourakis M, Agnantis N. Sivridis E, et al. Among authors: giatromanolaki a. Virchows Arch. 2000 Jan;436(1):52-8. doi: 10.1007/pl00008198. Virchows Arch. 2000. PMID: 10664162

8

Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.

Koukourakis MI, Giatromanolaki A, Fountzilas G, Sivridis E, Gatter KC, Harris AL. Koukourakis MI, et al. Among authors: giatromanolaki a. Clin Cancer Res. 2000 Feb;6(2):381-9. Clin Cancer Res. 2000. PMID: 10690514

9

c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.

Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G. Giatromanolaki A, et al. Anticancer Res. 2000 Mar-Apr;20(2A):997-1004. Anticancer Res. 2000. PMID: 10810387

10

Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.

Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Cox G, Thorpe PE, Gatter KC, Harris AL. Giatromanolaki A, et al. Clin Cancer Res. 2000 May;6(5):1917-21. Clin Cancer Res. 2000. PMID: 10815916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters